Kristine Dionisio Watford, MD
Pain Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 8
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
8 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Watford’s office at (408) 528-8833 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A153834 · Current
Licensed to practise in California · since 2018 · expires 2027-03-31 · University of Washington School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
- American Board of Anesthesiology - Pain Medicine
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 34% of their 379 Part D prescriptions in 2022. Long-acting opioids: 23% of their opioid prescriptions.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 379 | 67 | 34% (129) | 4% | $20,471 |
| 2021 | 549 | 74 | 38% (209) | 2% | $25,900 |
| 2020 | 696 | 101 | 44% (304) | 7% | $45,046 |
| 2019 | 277 | 91 | 23% (63) | 10% | $19,200 |
| 2018 | 30 | 18 | None | None | $932 |
| 2016 | 12 | None | None | None | $567 |
| 2015 | 32 | None | None | None | $3,146 |
| 2014 | 20 | None | None | None | $1,879 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 14 drugs
| Celecoxib | 35 | $2,060 | $59 |
| Buprenorphine-Naloxone | 12 | $1,987 | $166 |
| Buprenorphine | 21 | $1,179 | $56 |
| Hydrocodone-Acetaminophen | 35 | $927 | $26 |
| Oxycodone-Acetaminophen | 19 | $749 | $39 |
| Gabapentin | 51 | $715 | $14 |
| Pregabalin | 15 | $441 | $29 |
| Cyclobenzaprine | 15 | $372 | $25 |
| Methocarbamol | 17 | $334 | $20 |
| Oxycodone | 15 | $167 | $11 |
| Tramadol | 18 | $151 | $8 |
| Tizanidine | 11 | $95 | $9 |
| Methadone | 11 | $82 | $7 |
| Meloxicam | 14 | $32 | $2 |
2021: 16 drugs
| Celecoxib | 93 | $3,577 | $38 |
| Hydrocodone-Acetaminophen | 63 | $1,874 | $30 |
| Oxycodone-Acetaminophen | 39 | $1,852 | $47 |
| Buprenorphine | 20 | $1,209 | $60 |
| Duloxetine | 17 | $910 | $54 |
| Lidocaine | 15 | $830 | $55 |
| Gabapentin | 54 | $810 | $15 |
| Oxycodone | 27 | $804 | $30 |
| Morphine Sulfate Er | 18 | $536 | $30 |
| Methocarbamol | 12 | $402 | $33 |
| Cyclobenzaprine | 28 | $389 | $14 |
| Baclofen | 23 | $386 | $17 |
| Carisoprodol | 16 | $207 | $13 |
| Methadone | 16 | $149 | $9 |
| Tramadol | 16 | $62 | $4 |
| Meloxicam | 12 | $40 | $3 |
2020: 23 drugs
| Belbuca | 12 | $9,669 | $806 |
| Oxycontin | 22 | $6,544 | $297 |
| Buprenorphine-Naloxone | 12 | $4,957 | $413 |
| Oxycodone-Acetaminophen | 57 | $4,086 | $72 |
| Buprenorphine | 29 | $3,717 | $128 |
| Celecoxib | 72 | $3,628 | $50 |
| Fentanyl | 13 | $3,278 | $252 |
| Hydrocodone-Acetaminophen | 69 | $1,420 | $21 |
| Morphine Sulfate Er | 23 | $1,048 | $46 |
| Gabapentin | 61 | $966 | $16 |
| Oxymorphone | 13 | $694 | $53 |
| Baclofen | 23 | $502 | $22 |
| Morphine Sulfate | 12 | $493 | $41 |
| Duloxetine | 24 | $391 | $16 |
| Oxycodone | 41 | $389 | $9 |
| Carisoprodol | 22 | $389 | $18 |
| Pregabalin | 11 | $362 | $33 |
| Cyclobenzaprine | 24 | $357 | $15 |
| Tizanidine | 15 | $318 | $21 |
| Meloxicam | 35 | $230 | $7 |
| Methadone | 24 | $141 | $6 |
| Cephalexin | 18 | $90 | $5 |
| Tramadol | 15 | $50 | $3 |
2019: 6 drugs
| Gabapentin | 74 | $1,482 | $20 |
| Oxycodone-Acetaminophen | 16 | $1,236 | $77 |
| Celecoxib | 25 | $1,159 | $46 |
| Hydrocodone-Acetaminophen | 14 | $408 | $29 |
| Baclofen | 19 | $376 | $20 |
| Oxycodone | 11 | $106 | $10 |
Money from drug and device companies
$246 in 2022
| 2022 | 4 | 6 | None | $246 |
| 2021 | 9 | 62 | None | $1,040 |
| 2020 | 8 | 109 | None | $1,947 |
| 2019 | 2 | 22 | None | $1,533 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $142 | 1 payment
|
| Boston Scientific | General - Pain Management | $39 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $36 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $29 | 1 payment
|
See all 6 published payments
| Nalu Medical | Meals · 2022-06-06 | Nalu Neurostimulation System | $29 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-04-21 | Nurtec Odt | $18 |
| Boston Scientific | Meals · 2022-03-30 | General - Pain Management | $26 |
| Boston Scientific | Meals · 2022-03-05 | General - Pain Management | $13 |
| Stimwave Technologies | Meals · 2022-02-25 | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $142 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-02-19 | Nurtec Odt | $18 |
See earlier years (2021, 2020, 2019)
2021: $1,040
| Boston Scientific | General - Pain Management | $499 | 48 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $293 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $69 | 3 payments
|
| Painteq | Painteq | $47 | 1 payment
|
| AbbVie | Ubrelvy | $36 | 2 payments
|
| Vertos Medical | Mild Device Kit | $29 | 1 payment
|
| Allergan | Botox | $24 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $23 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $19 | 1 payment
|
2020: $1,947
| Boston Scientific | General - Pain Management | $1,295 | 85 payments
|
| Stimwave Technologies | Cfns Stimq Peripheral Nerve Stimulatorsystem | $482 | 17 payments
|
| Allergan | Botox | $46 | 2 payments
|
| Vertos Medical | Mild Device Kit | $38 | 1 payment
|
| Si-Bone | Ifuse Implant | $32 | 1 payment
|
| Spinal Simplicity | Minuteman | $22 | 1 payment
|
| Medtronic USA | Mystim | $17 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $15 | 1 payment
|
2019: $1,533
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $1,066 | 7 payments
|
| Boston Scientific | Spectra Wavewriter | $467 | 15 payments
|
Professional record
- NPI
- 1346668241
- Licence
- CA A153834California A153834: Current · expires 2027-03-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X)
- Mailing address
- 1604 Blossom Hill Road, Suite 10, San Jose, CA, 95124
- NPI first listed
- 2014-03-29
- NPI last updated
- 2020-11-25
- NPI record certified
- 2020-11-25
This is when the NPI record was last certified, not a medical board exam.